Clinical Evidence for CNS-Selective Therapeutics

You already know the limitations of current cholinesterase inhibitors. You’ve watched patients struggle with the tolerability-efficacy trade-off and had the conversation about ‘managing expectations’ more times than you can count. Here’s the science behind what comes next.